Global End Period Cash Flow vs Other Non Cash Items Analysis

GLH Stock

0.14 0.01 7.69%

Global Health financial indicator trend analysis is much more than just examining Global Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Global Health is a good investment. Please check the relationship between Global Health End Period Cash Flow and its Other Non Cash Items accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

End Period Cash Flow vs Other Non Cash Items

End Period Cash Flow vs Other Non Cash Items Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Global Health End Period Cash Flow account and Other Non Cash Items. At this time, the significance of the direction appears to have very week relationship.

The correlation between Global Health's End Period Cash Flow and Other Non Cash Items is 0.24. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Other Non Cash Items in the same time period over historical financial statements of Global Health, assuming nothing else is changed. The correlation between historical values of Global Health's End Period Cash Flow and Other Non Cash Items is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Global Health are associated (or correlated) with its Other Non Cash Items. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Non Cash Items has no effect on the direction of End Period Cash Flow i.e., Global Health's End Period Cash Flow and Other Non Cash Items go up and down completely randomly.

Correlation Coefficient

0.24

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

End Period Cash Flow

Other Non Cash Items

Most indicators from Global Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Global Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Tax Provision is likely to gain to about 335.3 K in 2024, whereas Selling General Administrative is likely to drop slightly above 784.2 K in 2024.

	2021	2022	2023	2024 (projected)
Other Operating Expenses	8.5M	11.5M	9.9M	7.2M
Interest Expense	27.7K	17.8K	76.3K	61.6K

Other Operating Expenses Interest Expense

Global Health fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Retained Earnings	Short Term Investments
Common Stock Shares Outstanding		-0.25	0.03	0.36	0.78	-0.57	-0.36	0.82	-0.02	0.31	0.0	-0.56	0.32	0.0	-0.07	-0.58	0.66	0.02	0.08	0.55	-0.29	0.0	-0.38	0.84	-0.87	-0.03
Total Assets	-0.25		0.23	-0.32	-0.13	0.85	0.32	-0.12	-0.62	-0.19	0.75	0.74	0.24	0.75	0.37	0.54	-0.51	0.22	-0.52	0.02	-0.42	0.84	0.34	-0.38	0.65	0.27
Short Long Term Debt Total	0.03	0.23		0.24	0.24	-0.15	0.45	-0.02	0.44	0.06	-0.2	0.29	-0.1	-0.2	0.55	-0.08	0.07	0.96	0.16	0.65	-0.48	-0.05	0.42	-0.14	0.01	0.05
Other Current Liab	0.36	-0.32	0.24		0.42	-0.5	-0.34	0.23	0.36	0.18	-0.32	-0.14	-0.62	-0.32	-0.33	-0.54	0.55	0.27	0.06	0.55	0.15	-0.38	-0.09	0.44	-0.48	-0.09
Total Current Liabilities	0.78	-0.13	0.24	0.42		-0.51	-0.09	0.93	0.08	0.59	-0.02	-0.21	0.34	-0.02	-0.02	-0.58	0.75	0.27	-0.09	0.85	-0.45	-0.01	-0.19	0.82	-0.75	0.11
Total Stockholder Equity	-0.57	0.85	-0.15	-0.5	-0.51		0.26	-0.4	-0.66	-0.35	0.7	0.71	0.12	0.7	0.21	0.7	-0.68	-0.12	-0.49	-0.45	-0.06	0.75	0.25	-0.56	0.87	0.19
Property Plant And Equipment Net	-0.36	0.32	0.45	-0.34	-0.09	0.26		-0.17	0.35	0.12	-0.23	0.64	0.16	-0.23	0.74	0.11	-0.14	0.48	-0.05	0.12	-0.35	-0.05	0.34	-0.37	0.41	-0.06
Current Deferred Revenue	0.82	-0.12	-0.02	0.23	0.93	-0.4	-0.17		-0.14	0.45	0.14	-0.32	0.45	0.14	-0.06	-0.48	0.71	0.05	-0.14	0.63	-0.36	0.13	-0.25	0.87	-0.72	0.13
Net Debt	-0.02	-0.62	0.44	0.36	0.08	-0.66	0.35	-0.14		0.32	-0.97	-0.09	-0.38	-0.97	0.22	-0.59	0.44	0.44	0.38	0.3	0.17	-0.89	0.14	0.05	-0.32	-0.49
Accounts Payable	0.31	-0.19	0.06	0.18	0.59	-0.35	0.12	0.45	0.32		-0.32	0.03	0.24	-0.32	0.06	-0.63	0.51	0.1	-0.21	0.46	-0.1	-0.27	-0.16	0.47	-0.45	-0.35
Cash	0.0	0.75	-0.2	-0.32	-0.02	0.7	-0.23	0.14	-0.97	-0.32		0.21	0.37	1.0	-0.08	0.62	-0.45	-0.2	-0.4	-0.14	-0.31	0.96	-0.03	-0.09	0.37	0.55
Non Current Assets Total	-0.56	0.74	0.29	-0.14	-0.21	0.71	0.64	-0.32	-0.09	0.03	0.21		-0.08	0.21	0.36	0.28	-0.33	0.32	-0.55	0.05	-0.18	0.31	0.52	-0.48	0.72	-0.02
Non Currrent Assets Other	0.32	0.24	-0.1	-0.62	0.34	0.12	0.16	0.45	-0.38	0.24	0.37	-0.08		0.37	0.29	0.16	-0.03	-0.14	0.02	0.07	-0.58	0.43	-0.17	0.18	-0.09	0.28
Cash And Short Term Investments	0.0	0.75	-0.2	-0.32	-0.02	0.7	-0.23	0.14	-0.97	-0.32	1.0	0.21	0.37		-0.08	0.62	-0.45	-0.2	-0.4	-0.14	-0.31	0.96	-0.03	-0.09	0.37	0.55
Net Receivables	-0.07	0.37	0.55	-0.33	-0.02	0.21	0.74	-0.06	0.22	0.06	-0.08	0.36	0.29	-0.08		0.04	-0.06	0.6	0.14	0.19	-0.35	0.18	0.14	-0.19	0.23	-0.19
Good Will	-0.58	0.54	-0.08	-0.54	-0.58	0.7	0.11	-0.48	-0.59	-0.63	0.62	0.28	0.16	0.62	0.04		-0.9	-0.14	0.06	-0.52	-0.14	0.59	0.08	-0.72	0.77	0.66
Common Stock Total Equity	0.66	-0.51	0.07	0.55	0.75	-0.68	-0.14	0.71	0.44	0.51	-0.45	-0.33	-0.03	-0.45	-0.06	-0.9		0.18	-0.03	0.62	0.02	-0.44	-0.13	0.88	-0.81	-0.42
Non Current Liabilities Total	0.02	0.22	0.96	0.27	0.27	-0.12	0.48	0.05	0.44	0.1	-0.2	0.32	-0.14	-0.2	0.6	-0.14	0.18		0.12	0.65	-0.4	-0.03	0.4	-0.04	0.0	-0.03
Other Stockholder Equity	0.08	-0.52	0.16	0.06	-0.09	-0.49	-0.05	-0.14	0.38	-0.21	-0.4	-0.55	0.02	-0.4	0.14	0.06	-0.03	0.12		-0.05	-0.01	-0.38	-0.35	-0.1	-0.22	0.24
Total Liab	0.55	0.02	0.65	0.55	0.85	-0.45	0.12	0.63	0.3	0.46	-0.14	0.05	0.07	-0.14	0.19	-0.52	0.62	0.65	-0.05		-0.54	-0.07	0.06	0.56	-0.54	0.08
Property Plant And Equipment Gross	-0.29	-0.42	-0.48	0.15	-0.45	-0.06	-0.35	-0.36	0.17	-0.1	-0.31	-0.18	-0.58	-0.31	-0.35	-0.14	0.02	-0.4	-0.01	-0.54		-0.39	0.02	-0.12	0.07	-0.48
Total Current Assets	0.0	0.84	-0.05	-0.38	-0.01	0.75	-0.05	0.13	-0.89	-0.27	0.96	0.31	0.43	0.96	0.18	0.59	-0.44	-0.03	-0.38	-0.07	-0.39		0.0	-0.11	0.41	0.45
Short Term Debt	-0.38	0.34	0.42	-0.09	-0.19	0.25	0.34	-0.25	0.14	-0.16	-0.03	0.52	-0.17	-0.03	0.14	0.08	-0.13	0.4	-0.35	0.06	0.02	0.0		-0.43	0.41	-0.17
Common Stock	0.84	-0.38	-0.14	0.44	0.82	-0.56	-0.37	0.87	0.05	0.47	-0.09	-0.48	0.18	-0.09	-0.19	-0.72	0.88	-0.04	-0.1	0.56	-0.12	-0.11	-0.43		-0.87	-0.18
Retained Earnings	-0.87	0.65	0.01	-0.48	-0.75	0.87	0.41	-0.72	-0.32	-0.45	0.37	0.72	-0.09	0.37	0.23	0.77	-0.81	0.0	-0.22	-0.54	0.07	0.41	0.41	-0.87		0.18
Short Term Investments	-0.03	0.27	0.05	-0.09	0.11	0.19	-0.06	0.13	-0.49	-0.35	0.55	-0.02	0.28	0.55	-0.19	0.66	-0.42	-0.03	0.24	0.08	-0.48	0.45	-0.17	-0.18	0.18

Click cells to compare fundamentals

Global Health Account Relationship Matchups

Global Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	39.0M	42.4M	56.0M	57.5M	58.0M	61.0M
Total Assets	6.6M	9.0M	11.0M	3.1M	3.1M	5.3M
Short Long Term Debt Total	816.4K	304.1K	141.8K	44.9K	1.0M	1.1M
Other Current Liab	1.0M	1.5M	1.2M	1.5M	1.6M	1.2M
Total Current Liabilities	4.9M	4.7M	4.8M	4.7M	5.1M	3.6M
Total Stockholder Equity	1.2M	4.0M	6.1M	(1.6M)	(2.9M)	(2.8M)
Property Plant And Equipment Net	236.8K	8.6K	9.7K	8.8K	20.5K	19.4K
Current Deferred Revenue	2.6M	2.4M	2.9M	2.5M	3.0M	1.7M
Net Debt	150.1K	(4.5M)	(6.2M)	(2.2M)	(1.0M)	(1.1M)
Accounts Payable	673.9K	619.1K	579.4K	625.4K	334.9K	476.3K
Cash	666.3K	4.8M	6.4M	2.2M	2.1M	1.5M
Non Current Assets Total	4.6M	3.5M	3.9M	8.9K	20.5K	19.4K
Non Currrent Assets Other	(448.2K)	116.4K	150.4K	(8.9K)	(1.0)	(1.05)
Cash And Short Term Investments	666.3K	4.8M	6.4M	2.2M	2.1M	1.5M
Net Receivables	1.2M	550.5K	492.7K	703.7K	819.6K	893.5K
Liabilities And Stockholders Equity	6.6M	9.0M	11.0M	3.1M	3.1M	5.3M
Non Current Liabilities Total	615.0K	339.9K	125.0K	46.6K	862.6K	493.3K
Total Liab	5.5M	5.0M	4.9M	4.7M	6.0M	4.3M
Property Plant And Equipment Gross	236.8K	211.5K	213.4K	213.3K	192.0K	182.4K
Total Current Assets	2.0M	5.5M	7.2M	3.1M	3.1M	2.6M
Accumulated Other Comprehensive Income	292.1K	1.1M	2.1M	2.0M	81.4K	77.3K
Short Term Debt	541.8K	162.3K	141.8K	(3.3M)	179.3K	188.2K
Common Stock	21.7M	24.4M	27.3M	27.7M	27.7M	20.9M
Retained Earnings	(20.9M)	(21.4M)	(23.3M)	(31.3M)	(30.7M)	(29.1M)
Other Current Assets	114.0K	140.5K	251.5K	163.0K	170.4K	222.4K
Intangible Assets	4.1M	4.1M	3.9M	3.0M	3.5M	0.0
Other Liab	1.4M	198.1K	184.5K	46.6K	53.6K	50.9K
Other Assets	508.1K	540.9K	414.4K	0.0	1.0	0.95
Property Plant Equipment	236.8K	8.6K	9.7K	8.8K	7.9K	7.5K
Net Tangible Assets	(3.7M)	1.1M	2.6M	(1.6M)	(1.9M)	(2.0M)
Short Long Term Debt	360.1K	159.5K	141.1K	44.9K	40.4K	38.4K
Long Term Investments	116.4K	118.4K	240.0	109.0	125.35	119.08

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Global Stock Analysis

When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC